Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 812-815

  Gillespie, Matthew T ^a,c   Thomas, Rachel J ^a   Pu, Zhao Yan ^a   Zhou, Hong ^a   Martin, T John ^a   Findlay, David M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE SIALOPROTEIN; CALCITONIN RECEPTOR; CYTOKINE; MESSENGER RNA; OSTEOPONTIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; METABOLISM; PAGET NIPPLE DISEASE; POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYTOKINES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITONIN; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0031564108     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971210)73:6<812::AID-IJC7>3.0.CO;2-5     Document Type: Article

References (17)

1. BEHREND, E.I., CRAIG, A.M., WILSON, S.M., DENHARDT, D.T. and CHAMBERS, A.F., Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res., 54, 832-837 (1994).
2. BELLAHCÈNE, A. and CASTRONOVO, V., Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Amer. J. Pathol., 146, 95-100 (1995).
3. BELLAHCÈNE, A., MERVILLE, M.-P. and CASTRONOVO, V., Expression of bone salioprotein, a bone matrix protein, in human breast cancer. Cancer Res., 54, 2823-2826 (1994).
4. BUTLER, W.T., The nature and significance of osteopontin. Connect. Tissue Res., 23, 123-126 (1989).
5. CHAMBERS, T.J. and MAGNUS, C.J., Calcitonin alters behaviour of isolated osteoclasts. J. Pathol., 136, 27-39 (1982).
6. CHO-CHUNG, Y.S., Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res., 50, 7093-7100 (1990).
7. 3 receptors in human breast cancer cell lines. Cancer Res., 40, 4764-4767 (1980).
8. GORN, A.H., LIN, H.Y., YAMIN, M., AURON, P.E., FLANNERY, M.R., TAPP, D.R., MANNING, C.A., LODISH, H.F., KRANE, S.M. and GOLDRING, S.R., Cloning characterisation, and expression of a human Calcitonin receptor from an ovarian carcinoma cell line. J. clin. Invest., 90, 1726-1735 (1992).
9. HOFLAND, L.J. and LAMBERTS, S.W., Somatostatin receptors and disease: role of receptor subtypes. Baillières Clin. Endocrinol. Metab., 10, 163-176 (1996).
10. KUESTNER, R.E. and 13 OTHERS, Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol. Pharmacol., 46, 246-255 (1994).
11. MARTIN, T.J. and MOSELEY, J.M., Calcitonin. In: L. V. Alvioli and S.M. Krane (eds.), Metabolic bone diseases and clinically related disorders, pp. 131-154, W.B. Saunders, Philadelphia (1990).
12. MOORE, E.E., KUESTNER, R.E., STROOP, S.D., GRANT, F.J., MATTHEWES, S.L., BRADY, C.L., SEXTON, P.M. and FINDLAY, D.M., Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcripts. Mol. Endocrinol., 9, 959-968 (1995).
13. MUNDY, G.R. and MARTIN, T.J., Pathophysiology of skeletal complications of cancer. In: G.R. Mundy and T.J. Martin (eds.), Physiology and pharmacology of bone, Handbook of experimental pharmacology, pp. 642-671, Springer-Verlag, Berlin (1993).
14. NG, K.W., LIVESEY, S.A., LARKINS, R.G. and MARTIN, T.J., Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3′:5′-monophosphate-dependent protein kinase in T47D human breast cancer cells. Cancer Res., 43, 794-800 (1983).
15. OATES, A.J., BARRACLOUGH, R. and RUDLAND, P.S., The indentification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene, 13, 97-104 (1996).
16. SOUTHBY, J., O'KEEFFE, L.M., MARTIN, T.J. and GILLESPIE, M.T., Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Brit. J. Cancer, 72, 702-707 (1995).
17. ZHOU, H., CHOONG, P., MCCARTHY, R., CHOU, S.T., MARTIN, T.J. and NG, K.W., In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J. Bone Miner. Res., 9, 1489-1499 (1994).